Lawrence Blonde, MD, FACP, FACE

home / authors / lawrence-blonde-md-facp-face

Articles

November 30th 2012

Achieving Antihyperglycemic Treatment Goals With Incretin-Related Therapies

The management of type 2 diabetes mellitus (T2DM) remains challenging. Limitations associated with many current therapies include hypoglycemia and weight gain. An increased understanding of the pathophysiology of T2DM has led to the development of incretin-related antihyperglycemic therapies.

November 11th 2011

Improving Care for Patients With Type 2 Diabetes: Applying Management Guidelines and Algorithms, and a Review of New Evidence for Incretin Agents and Lifestyle Intervention

Lawrence Blonde, MD, FACP, FACE

August 1st 2005

Best Practices in Diabetes Management: Getting More Patients to Goal

Lawrence Blonde, MD, FACP, FACE

August 1st 2005

The Road Ahead in Diabetes Management

Lawrence Blonde, MD, FACP, FACE